UNSPSC 85818818: Transfusion of nonautologous bone marrow into central artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous bone marrow into central artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30260G1

UNSPSC 85818818 Transfusion of nonautologous bone marrow into central artery, open approach (Commodity) describes a specific clinical procedure, but recent state and local opportunities tagged under this code do not align with bone marrow transfusion services. Instead, the opportunities posted under this code span occupational health surveillance, disability medical evaluation, surgical benefit management, pharmacy benefit administration, and temporary health professional staffing—none of which involve bone marrow procedures. The issuing bodies include city retirement offices, state transportation departments, county health systems, county boards of commissioners, and county juvenile probation departments, indicating a mix of municipal, county, and state health and human services buyers. The lack of coherence between the code's nominal scope and actual procurement activity suggests either a tagging error in source systems or a code that sees little relevant recent activity in state and local procurement.

Geographic activity across recent opportunities spans Arizona, Washington, California, Texas, and Florida. The City of Phoenix Retirement Office posted RFP RTMRFP26001 in September 2026 seeking independent medical evaluation services for disability pension determinations with a response date of October 16, 2026; the Washington State Department of Transportation posted RFP RFP20260825 for occupational medical surveillance services with proposals due October 9, 2026; and the County of Santa Clara Health System solicited temporary health professional staffing across multiple ancillary clinical categories with a response date of October 7, 2026. Given the mismatch between code definition and procurement substance, business development professionals should verify code assignment before pursuing opportunities in this category.